Meg Jardine, MBBS: Impact of CREDENCE Study

(3:9)

PKDOC: Adaptive Clinical Trials - Meg Jardine Presentation

(54:31)

Meg Jardine, MBBS, PhD: Canagliflozin on Total Heart Failure Hospitalizations

(2:26)

Meg Jardine, MBBS, PhD: Mediators of Canagliflozin Effect on Heart Failure and CV Death

(3:23)

Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria

(4:46)

ASN Highlights Podcast

(30:13)

The CMF Podcast - Episode 8

(19:49)

ASN Congress Highlights Pt1

(28:26)

KDIGO-IACN Joint Symposium: Diabetic Kidney Disease

(59:43)

The Silent Killer: Why biotechs are all in on kidney disease, with University of Sydney CTC and C...

(26:56)

Kidney Week 2024 Day 3: Late Breaking Clinical Trials

(25:56)

ASN Congress Highlights Pt2

(37:36)

Educational webinar: New treatments for preventing chronic kidney disease progression

(1:19:5)

KDIGO-IACN Joint Symposium: IgA Nephropathy

(51:51)

The Silent Killer: The sci-fi episode, with Certa Therapeutics and University of Sydney CTC

(28:)

Kidney Week 2024: High-Impact Clinical Trials - 1

(1:50:45)

KDIGO Potassium Management

(25:35)

What is MEG?

(5:38)

POV: Meg reveals herself to Hercules⚡️ #disney #hercules #shorts #acting #duet

(12)